technologyAug 7, 202437:55pending
Recursion CEO Chris Gibson on Accelerating the Biopharmaceutical Industry With AI - Ep. 230
About this episode
Techbio is a field combining data, technology and biology to enhance scientific processes — and AI has the potential to supercharge the biopharmaceutical industry further. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Chris Gibson, cofounder and CEO of Recursion, about how the company uses AI and machine learning to accelerate drug discovery and development at scale. Tune in to hear Gibson discuss how AI is transforming the biopharmaceutical industry by increasing efficiency and lowering discovery costs.
Get every episode summarized
Each time NVIDIA AI Podcast publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from NVIDIA AI Podcast
How AI Will Change Quantum Computing - Ep. 294
NVIDIA AI Podcast
Apr 14, 202631:28failed
Building AI Factories: How Red Hat and NVIDIA Turn Enterprise Data Into Intellig...
NVIDIA AI Podcast
Mar 12, 202638:43failed
Powering the AI Inference Wave with EPRI's Ben Sooter - Ep. 292
NVIDIA AI Podcast
Mar 4, 202632:20pending
AI Agents and the Future of Global Trade with Alibaba’s Kuo Zhang - Ep. 291
NVIDIA AI Podcast
Feb 27, 202633:13pending